MedPath

Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

Phase 2
Completed
Conditions
Ileus
Interventions
Drug: placebo
Registration Number
NCT00672074
Lead Sponsor
Helsinn Therapeutics (U.S.), Inc
Brief Summary

The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.

Detailed Description

The safety and efficacy of ipamorelin in the management of post-operative ileus

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
117
Inclusion Criteria
  • willing to comply with protocol
  • undergoing bowel resection surgery
  • ASA Class I-III
  • Females must not be pregnant
  • Body weight 40-150 kg
Exclusion Criteria
  • mentally incompetent or unable to provide informed consent
  • clinically unstable
  • significant liver disease
  • clinically significant lab or EKG abnormalities
  • alcohol or illicit drug abuse
  • history of or current surgery that would prevent proper evaluation of safety or efficacy of drug

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2 Placeboplacebo-
1 IpamorelinIpamorelin-
Primary Outcome Measures
NameTimeMethod
Recovery of GI functionUntil hospital discharge
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (19)

USC/Norris Cancer Center

🇺🇸

Los Angeles, California, United States

Cedars Sinai Medical Center

🇺🇸

Los Angeles, California, United States

Palo Alto Veterans Hospital

🇺🇸

Palo Alto, California, United States

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

Denver VA Hospital

🇺🇸

Denver, Colorado, United States

Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Cleveland Clinic of Weston

🇺🇸

Weston, Florida, United States

St. Joseph's Hospital of Atlanta

🇺🇸

Atlanta, Georgia, United States

University of Illinois at Chicago

🇺🇸

Chicago, Illinois, United States

Indiana University Medical Center

🇺🇸

Indianapolis, Indiana, United States

Scroll for more (9 remaining)
USC/Norris Cancer Center
🇺🇸Los Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.